Salvador
Martín Algarra
Consultor Médico
Hospital de la Santa Creu i Sant Pau
Barcelona, España
Publications in collaboration with researchers from Hospital de la Santa Creu i Sant Pau (9)
2026
-
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry
Clinical and Translational Oncology, Vol. 28, Núm. 2, pp. 645-653
-
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801
Clinical and Translational Oncology, Vol. 28, Núm. 5, pp. 1807-1814
-
Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: results from the real-world Spanish Melanoma Registry (GEM-1801)
Clinical and Translational Oncology, Vol. 28, Núm. 1, pp. 320-329
-
Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801
Clinical and Translational Oncology, Vol. 28, Núm. 6, pp. 2377-2385
2025
-
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis
Clinical and Translational Oncology, Vol. 27, Núm. 1, pp. 386-391
-
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study
Melanoma Research, Vol. 35, Núm. 6, pp. 399-408
2024
-
Access to melanoma drugs in Spain: a cross-sectional survey
Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2572-2583
2023
-
SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
Clinical and Translational Oncology, Vol. 25, Núm. 3, pp. 768-775
2015
-
Frequency and characteristics of familial melanoma in Spain: The FAM-GEM-1 study
PLoS ONE, Vol. 10, Núm. 4